Raising NAD+ levels in humans
Multiple human RCTs (Martens 2018, Dellinger 2017, Brakedal 2022) confirm that oral NR or NRPT consistently raises blood NAD+ levels by 40-100% in healthy and clinical populations. The biochemistry is well-established. The harder question — does raising NAD+ produce clinically meaningful aging or disease outcomes — is much less settled.
6 human studies · 12 animal studies
Key findings & citations
- Martens 2018: chronic NR safely elevates NAD+ in healthy older adults.
- Dellinger 2017 (NRPT): ~40-90% NAD+ elevation in 60-80 year olds.
- Brakedal 2022 (NADPARK Phase 1): NR raised NAD+ in newly-diagnosed PD patients.
- Mecomb 2024: Acute NR raises cerebral NAD+ in vivo in healthy volunteers.
Our take
NAD+ goes up. That's the part that's settled. Whether that translates to slower aging or fewer diseases is mostly still hopeful biomarker work.